Health Care
Health care reform must ensure that quality coverage is affordable and accessible for every American, regardless of income or pre-existing conditions. But it must not force Americans into a government-run health care system that would eliminate coverage they receive from their employer. Every American should have the right to choose the health plan that best meets their needs, and medical decisions must be made by patients and doctors, not government bureaucrats.
In 2009, I founded the Childhood Cancer Caucus to increase bipartisan efforts to address pediatric cancer and ultimately eliminate this heartbreaking disease. Click here to read more about my work as chair of the caucus: https://childhoodcancer-mccaul.house.gov/
More on Health Care
October 23, 2015
WASHINGTON, DC– Today, following the passage of H.R. 3762 – Restoring Americans’ Healthcare Freedom Reconciliation Act, Representative Michael McCaul (TX-10) issued the following statement about the bill:
Issues:EconomyHealth Care
September 18, 2015
WASHINGTON, DC– Today following the House vote to withdraw taxpayer money from Planned Parenthood, Congressman Michael McCaul (R-TX) made the following statement:
Issues:Health Care
July 29, 2015
WASHINGTON, DC – Today Congressman Michael McCaul introduced the bipartisan, bicameral Childhood Cancer Survivorship, Treatment, Access, and Research (STAR) Act of 2015. Congressman McCaul was joined by his fellow co-chair of the Childhood Cancer Caucus Congressman Chris Van Hollen (D-MD) as well as Congresswoman Jackie Speier (D-CA) in introducing the legislation in the House and Senator Jack Reed (D-RI) and Senator Shelley Moore Capito (R-WV) introduced the legislation in the Senate.
Issues:Health Care
July 10, 2015
WASHINGTON, DC – Today, following passage of H.R. 6, the 21st Century Cures Act, Representative Michael McCaul (TX-10) issued the following statement about the bill including two provisions which he spearheaded:
Issues:Health Care
June 25, 2015
AUSTIN, TX – Following the Supreme Court’s decision to uphold ObamaCare subsidies in the King v. Burwell case, Congressman Michael McCaul (R-TX) released the following statement.
Issues:EconomyHealth Care
May 7, 2015
AUSTIN, TX – Today following the announcement that Johnson & Johnson will create an independent panel for compassionate use requests, Congressman Michael McCaul (R-TX) made the following statement.
Issues:Health Care
March 10, 2015
AUSTIN, TX – Today the Food and Drug Administration announced it has approved the first pediatric cancer drug due to the voucher program that became law under the Creating Hope Act. The drug, Unituxin, developed by United Therapeutics, designed to treat neuroblastoma, is only the third third drug to receive initial FDA approval for a pediatric cancer in the last 20 years. The Creating Hope Act was signed into law in 2011, and was sponsored by Representative Michael McCaul, Representative G.K. Butterfield, and Representative Chris Van Hollen.
Issues:Health Care
February 12, 2015
WASHINGTON, DC – Today, U.S. Representative Michael McCaul (R-TX) introduced H.R. 909, the Andrea Sloan Compassionate Use Reform and Enhancement (CURE) Act, which would make important reforms to the Food and Drug Administration’s (FDA) expanded access ("compassionate use") process, by ensuring seriously ill patients have the right to know the compassionate use policies of pharmaceutical companies developing the most innovative treatments. He was joined by Representative G.K. Butterfield (D-NC), Rep. Michael Burgess (R-TX), Rep. Doris Matsui (D-CA), Representative Morgan Griffith (R-VA), and Representative Leonard Lance (R-NJ). The bill is named after Andrea Sloan, an Austin resident who died on New Year's Day 2014 after being denied access to a potentially lifesaving drugs to treat her seven-year battle with ovarian cancer.
Issues:Health Care
December 8, 2014
WASHINGTON, DC – Today, U.S. Representative Michael McCaul (R-TX) introduced H.R. 5805, the Andrea Sloan Compassionate Use Reform and Enhancement (CURE) Act, which would make important reforms to the Food and Drug Administration’s (FDA) expanded access ("compassionate use") program, by ensuring seriously ill patients have the right to know the compassionate use policies of pharmaceutical companies. The bill is named after Andrea Sloan, an Austin resident who died on New Year's Day after being denied access to a potentially lifesaving drugs to treat her seven-year battle with ovarian cancer.
Issues:Health Care
September 19, 2014
Friends say Andrea Sloan would have loved to attend a summit this weekend in Washington, D.C., that will focus on research for childhood cancer and expanded access to experimental drugs for all cancer patients.
Sloan, 45, passed away earlier this year after a fight to gain access to an experimental drug to treat her ovarian cancer through a process called compassionate use. She was eventually granted access to a different drug made by a different company, but by then, her cancer had progressed too far.
Issues:Health Care